0001485003-21-000196.txt : 20211004
0001485003-21-000196.hdr.sgml : 20211004
20211004192939
ACCESSION NUMBER: 0001485003-21-000196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211001
FILED AS OF DATE: 20211004
DATE AS OF CHANGE: 20211004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryu Elly
CENTRAL INDEX KEY: 0001860740
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 211304653
MAIL ADDRESS:
STREET 1: 245 FIRST STREET, SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sesen Bio, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
wf-form4_163339016370662.xml
FORM 4
X0306
4
2021-10-01
0
0001485003
Sesen Bio, Inc.
SESN
0001860740
Ryu Elly
C/O SESEN BIO, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
0
1
0
0
Principal Accounting Officer
Common Stock
2021-10-01
4
A
0
115000
0
A
126696
D
Represents restricted stock units which vest in full on September 30, 2022, subject to recipient's continued employment through September 30, 2022. Each restricted stock unit represents a contingent right to receive one share of the Sesen Bio, Inc.'s common stock.
/s/ Mark R. Sullivan, as attorney-in-fact
2021-10-04